公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2014 | Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression | HSIN-AN HOU ; Kuo Y.-Y.; JIH-LUH TANG ; WEN-CHIEN CHOU ; MING YAO ; Lai Y.-J.; CHIEN-CHIN LIN ; Chen, Chien-Yuan ; Liu C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; SHANG-YI HUANG ; BOR-SHENG KO ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | American Journal of Hematology | 58 | 54 | |
2013 | Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression | SHANG-JU WU ; JIH-LUH TANG ; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; HSIN-AN HOU ; Chen, Chien-Yuan ; WEN-CHIEN CHOU ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; WOEI TSAY ; HWEI-FANG TIEN | American Journal of Hematology | 57 | 42 | |
2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | BOR-SHENG KO ; Wang, Yu-Fen; Li, Jeng-Lin; Li, Chi-Cheng; Weng, Pei-Fang; SZU-CHUN HSU ; HSIN-AN HOU ; HUAI-HSUAN HUANG ; MING YAO ; Lin, Chien-Ting; JIA-HAU LIU ; CHENG-HONG TSAI ; TAI-CHUNG HUANG ; SHANG-JU WU ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; HWEI-FANG TIEN ; Lee, Chi-Chun; JIH-LUH TANG | EBioMedicine | 52 | 45 | |
2022 | A Coarse-to-Fine Pathology Patch Selection for Improving Gene Mutation Prediction in Acute Myeloid Leukemia | Chiu, Chun-Chia; Li, Jeng-Lin; Wang, Yu-Fen; BOR-SHENG KO ; Lee, Chi-Chun | Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference | 1 | 0 | |
2011 | Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: A case report and literature review | Liu J.-Y.; Chen W.-T.; BOR-SHENG KO ; MING YAO ; PO-REN HSUEH ; Hsiao C.-H.; YU-MIN KUO ; YEE-CHUN CHEN | Medical Mycology | 36 | 34 | |
2008 | Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies | TAI-CHUNG HUANG ; BOR-SHENG KO ; JIH-LUH TANG ; CHIUN HSU ; Chen, Chien-Yuan ; WOEI TSAY ; SHANG-YI HUANG ; MING YAO ; YAO-CHANG CHEN ; MING-CHING SHEN ; Wang C.-H.; HWEI-FANG TIEN | Leukemia | 47 | 42 | |
2018 | Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA | FENG-MING TIEN ; HSIN-AN HOU ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chen, Chien-Yuan ; CHENG-HONG TSAI ; MING YAO ; Lin, Chien-Ting; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; JIA-HAU LIU ; SHENG-CHIEH CHOU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Haematologica | 25 | 21 | |
2017 | Cordycepin disrupts leukemia association with mesenchymal stromal cells and eliminates leukemia stem cell activity | Liang S.-M.; Lu Y.-J.; BOR-SHENG KO ; Jan Y.-J.; Shyue S.-K.; Yet S.-F.; Liou J.-Y. | Scientific Reports | 25 | 18 | |
2013 | Cordycepin Regulates GSK-3β/β-Catenin Signaling in Human Leukemia Cells | BOR-SHENG KO ; Lu Y.-J.; Yao W.-L.; Liu T.-A.; Tzean S.-S.; Shen T.-L.; Liou J.-Y. | PLoS ONE | 37 | 36 | |
2019 | Cordycepin suppresses endothelial cell proliferation, migration, angiogenesis, and tumor growth by regulating focal Adhesion Kinase and p53 | Lin Y.-T.; Liang S.-M.; Wu Y.-J.; Wu Y.-J.; Lu Y.-J.; Jan Y.-J.; BOR-SHENG KO ; Chuang Y.-J.; Shyue S.-K.; Kuo C.-C.; Liou J.-Y. | Cancers | 15 | 13 | |
2014 | Cordycepin suppresses integrin/FAK signaling and epithelial-mesenchymal transition in hepatocellular Carcinoma | Yao W.-L.; BOR-SHENG KO ; Liu T.-A.; Liang S.-M.; Liu C.-C.; Lu Y.-J.; Tzean S.-S.; Shen T.-L.; Liou J.-Y. | Anti-Cancer Agents in Medicinal Chemistry | 42 | 36 | |
2020 | Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan | Wang, Yu-Hung; SHAN-CHI YU ; BOR-SHENG KO ; YI-TSUNG YANG ; MING YAO ; JIH-LUH TANG ; TAI-CHUNG HUANG | International journal of hematology | 3 | 3 | |
2007 | Cyclooxygenase-2-derived prostaglandin E2 protects mouse embryonic stem cells from apoptosis | Liou J.-Y.; Ellent D.P.; Lee S.; Goldsby J.; BOR-SHENG KO ; Matijevic N.; Huang J.-C.; Wu K.K. | Stem Cells | 61 | 56 | |
2021 | Cytomegalovirus management after allogeneic hematopoietic stem cell transplantation: A mini-review | Jerry Teng C.-L.; Wang P.-N.; YEE-CHUN CHEN ; BOR-SHENG KO | Journal of Microbiology, Immunology and Infection | 18 | 17 | |
2011 | Development of immunity against hepatitis B virus after donor lymphocyte infusion in a peripheral blood stem cell transplantation recipient with chronic hepatitis B | Chiang L.-T.; MING YAO ; BOR-SHENG KO ; CHIEN-HUNG CHEN | Infection | 4 | 5 | |
2010 | Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation | WEN-CHIEN CHOU ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 179 | 173 | |
2010 | Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations | WEN-CHIEN CHOU ; HUAI-HSUAN HUANG ; HSIN-AN HOU ; Chen, Chien-Yuan ; JIH-LUH TANG ; MING YAO ; WOEI TSAY ; BOR-SHENG KO ; SHANG-JU WU ; SHANG-YI HUANG ; SZU-CHUN HSU ; YAO-CHANG CHEN ; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; HWEI-FANG TIEN | Blood | 176 | 160 | |
2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | FENG-MING TIEN ; CHENG-HONG TSAI ; Huang, Sheng-Chuan; JIA-HAU LIU ; Chen, Chien-Yuan ; YUAN-YEH KUO ; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; CHIA-WEN LIU ; Liao, Xiu-Wen; LIANG-IN LIN ; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU ; SZU-CHUN HSU ; BOR-SHENG KO ; WEN-CHIEN CHOU ; MING YAO ; HSIN-AN HOU ; JIH-LUH TANG ; HWEI-FANG TIEN | Bone marrow transplantation | 5 | 6 | |
2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | CHI-YUAN YAO ; HSIN-AN HOU ; Lin, Tzung-Yi; CHIEN-CHIN LIN ; WEN-CHIEN CHOU ; Tseng, Mei-Hsuan; Chiang, Ying-Chieh; Liu, Ming-Chih; Liu, Chia-Wen; Kuo, Yuan-Yeh; SHANG-JU WU ; Liao, Xiu-Wen; Lin, Chien-Ting; BOR-SHENG KO ; Chen, Chien-Yuan ; SZU-CHUN HSU ; Li, Chi-Cheng; SHANG-YI HUANG ; MING YAO ; JIH-LUH TANG ; WOEI TSAY ; Liu, Chieh-Yu; HWEI-FANG TIEN | Oncotarget | 19 | 18 | |
2012 | DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications | HSIN-AN HOU ; Kuo Y.-Y.; Liu C.-Y.; WEN-CHIEN CHOU ; Lee M.C.; Chen, Chien-Yuan ; LIANG-IN LIN ; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG ; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; YAO-CHANG CHEN ; HWEI-FANG TIEN | Blood | 195 | 184 | |